Closed · RFA-CA-14-502 · CFDA 93.393;93.394;93.395;93.396 · Discretionary

Limited Competition: AIDS Malignancy Clinical Trials Consortium (UM1)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $21.4M
Award range
Closed
Status
January 6, 2015
Close date
1
Expected awards

The verdict

Limited Competition: AIDS Malignancy Clinical Trials Consortium (UM1) is a closed discretionary listing from National Institutes of Health that offered Up to $21,400,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

up to $21.4M
award range
Closed
application status
1
expected award
93.393;93.394;93.395;93.396
CFDA program

Archived opportunity record

Limited Competition: AIDS Malignancy Clinical… is closed (last close January 6, 2015). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed January 6, 2015

Posted Aug 8 Closes Jan 6

Est. Total Funding

$21,400,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

The purpose of this limited competition funding opportunity announcement (FOA) is to continue support of the research activities of the AIDS Malignancy Consortium which are: 1) design, development, and evaluation of clinical interventions for the prevention and treatment of malignancies in patients with HIV infection; 2) development of more effective management and therapeutics for HIV-associated malignancies; 3) investigation of the biology of HIV malignancies within the context of clinical trials; 4) management of issues of international importance in HIV-associated-malignancies; and 5) distribution of excess tumor tissue and other relevant biologic fluids to the AIDS and Cancer Specimen Resource for ongoing or future investigations. In addition, the AMC is expected to continue the development and execution of the "ANCHOR" study on the treatment of anal cancer high-grade squamous intraepithelial lesions (HSIL) to reduce anal cancer. In the current funding period, the initiation of the ANCHOR study was supported through supplemental funding to AMC. The Consortium will consist of a coordinating center, clinical trials sites, network laboratories, and a statistical center. The Consortium will have at least four scientific disease-oriented Working Groups (WGs): 1) Kaposi sarcoma WG; 2) lymphoma WG; 3) WG for human papilloma virus-associated cancers; and 4) WG for non-AIDS-Defining Cancers.

Catch-all / unrestricted eligibility mark · RFA-CA-14-502

Grants.gov marks Limited Competition: AIDS Malignancy Clinical… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Education · Health (ED;HL). Only 187 other National Institutes of Health listings share this exact eligibility-code string (2% of 12,420).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Limited Competition: AIDS Malignancy Clinical… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.393;93.394;93.395;93.396 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants